Suppr超能文献

正常和子痫前期胎盘组织中fms样酪氨酸激酶-1变体的mRNA表达变异性。

Variability in mRNA expression of fms-like tyrosine kinase-1 variants in normal and preeclamptic placenta.

作者信息

Surmon Laura, Bobek Gabriele, Makris Angela, Chiu Christine L, Lind Craig A, Lind Joanne M, Hennessy Annemarie

机构信息

School of Medicine, University of Western Sydney, Building 30, Campbelltown Campus, Locked Bag 1797, Penrith, NSW 2751, Australia.

出版信息

BMC Res Notes. 2014 Mar 17;7:154. doi: 10.1186/1756-0500-7-154.

Abstract

BACKGROUND

Preeclampsia is a complication of pregnancy characterised by gestational hypertension and proteinuria and is a leading cause of morbidity and mortality in both mothers and infants. Certain anti-angiogenic factors have long been implicated in the pathogenesis of preeclampsia and the placental expression of factors such as soluble fms-like tyrosine kinase-1 (sFLT-1) are often reported in studies of normal and diseased placentae. Despite evidence showing significant differences in placental gene expression by collection site, many studies fail to provide sufficient details on sample selection and collection.

FINDINGS

With ourselves and others investigating and reporting on the expression of FLT-1 variants and other genes in the placenta of normotensive and preeclamptic patients, we felt it prudent to examine the variation in expression of FLT-1 variants across human placenta. We examined the differential expression of FLT-1 variants in samples obtained from 12 sites on normal and preeclamptic placentae and found expression to be highly variable between sites. We therefore developed an algorithim to calculate the mean expression for any number of these sites collected and in any combination. The coefficient of variation for all combinations of sites was then used to determine the minimum number of sites required to reduce coefficient of variation to below an acceptable 10%. We found that 10 and 11 sites had to be sampled in the normal and preeclamptic placentae respectively to ensure a representative expression pattern for all FLT-1 variants for an individual placenta.

CONCLUSIONS

These findings demonstrate significant variation in expression levels of several commonly investigated genes across sites in both normal and preeclamptic placenta. This highlights both the importance of adequate sampling of human placenta for expression studies and the effective communication of sample selection and collection methods, for data interpretation and to ensure the reproducibility and reliability of results and conclusions drawn.

摘要

背景

子痫前期是一种妊娠并发症,其特征为妊娠期高血压和蛋白尿,是导致母婴发病和死亡的主要原因。某些抗血管生成因子长期以来一直被认为与子痫前期的发病机制有关,在正常和患病胎盘的研究中,常报道可溶性fms样酪氨酸激酶-1(sFLT-1)等因子在胎盘的表达情况。尽管有证据表明胎盘基因表达因采集部位存在显著差异,但许多研究未能提供关于样本选择和采集的足够详细信息。

研究结果

我们自己以及其他研究人员对正常血压和子痫前期患者胎盘中FLT-1变体及其他基因的表达进行了调查和报道,我们认为审慎的做法是研究FLT-1变体在人胎盘各部位的表达差异。我们检测了从正常和子痫前期胎盘的12个部位获取的样本中FLT-1变体的差异表达,发现各部位之间的表达差异很大。因此,我们开发了一种算法,用于计算这些部位中任意数量的采集部位以任何组合方式采集时的平均表达量。然后,利用所有部位组合的变异系数来确定将变异系数降低到可接受的10%以下所需的最少部位数。我们发现,正常胎盘和子痫前期胎盘分别需要采集10个和11个部位的样本,才能确保单个胎盘所有FLT-1变体的代表性表达模式。

结论

这些发现表明,在正常和子痫前期胎盘中,几个常用研究基因的表达水平在不同部位存在显著差异。这突出了在表达研究中对人胎盘进行充分采样的重要性,以及有效交流样本选择和采集方法的重要性,以便进行数据解读,并确保所得到结果和结论的可重复性和可靠性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af1/3995530/43cc3884a697/1756-0500-7-154-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验